DGAP-PVR: STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with

DGAP-PVR: STRATEC Biomedical AG: Release according to Article 26, Section 1 of 
the WpHG [the German Securities Trading Act] with the objective of Europe-wide 
distribution

STRATEC Biomedical AG 

22.10.2013 10:09

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Allianz SE, Munich, Germany, has notified us pursuant to section 21 (1)
sentence 1 of the German Securities Trading Act (WpHG) on October 17, 2013
as follows:
 
'We hereby give notice pursuant to section 21 (1) in conjunction with § 24
of the German Securities Trading Act (WpHG) that the share of voting rights
held by Allianz Global Investors France S.A., Paris, France, in STRATEC
Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld, Germany, went above the
threshold of 3% on October 15, 2013 and amounted to 3.01% of all voting
rights of the company (this reflects 353,694 of all 11,747,745 voting
rights). These voting rights are attributable pursuant to section 22 (1)
sentence 1 number 6 of the German Securities Trading Act (WpHG).'



22.10.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------